LIST OF FIGURES
• FIGURE 1 RESEARCH DESIGN ........................................................................................................................................... 20
• FIGURE 2 BOTTOM-UP APPROACH .................................................................................................................................. 23
• FIGURE 3 TOP-DOWN APPROACH .................................................................................................................................... 24
• FIGURE 4 DATA TRIANGULATION ...................................................................................................................................... 25
• FIGURE 5 ASSUMPTIONS FOR THE RESEARCH STUDY ................................................................................................... 26
• FIGURE 6 HUMAN INSULIN MARKET SHARE , BY KEY PLAYER , 2014 .............................................................................. 27
• FIGURE 7 FUTURE TRENDS : HUMAN INSULIN MARKET SIZE , BY PRODUCT ( 2015 – 2020 )............................................ 28
• FIGURE 8 FUTURE TRENDS : HUMAN INSULIN DRUGS MARKET SHARE , BY TYPE ( 2015 VS . 2020 ).............................. 29
• FIGURE 9 FUTURE TRENDS : HUMAN INSULIN DRUGS MARKET SIZE , BY BRAND ( 2015 – 2020 ).................................... 29
• FIGURE 10 FUTURE TRENDS : HUMAN INSULIN DELIVERY DEVICES MARKET SIZE , BY PRODUCT TYPE ( 2015 – 2020 )...................................................................................................................... 30
• FIGURE 11 FUTURE TRENDS : HUMAN INSULIN MARKET SHARE , BY REGION ( 2015 )...................................................... 31
• FIGURE 12 ATTRACTIVE GROWTH OPPORTUNITIES IN THE HUMAN INSULIN MARKET ................................................... 32
• FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE HUMAN INSULIN MARKET IN 2015 ............................... 33
• FIGURE 14
NORTH AMERICA TO COMMAND THE LARGEST SHARE OF ALL SEGMENTS OF THE HUMAN INSULIN DELIVERY DEVICES MARKET IN 2015 .......................................................................... 34
• FIGURE 15 LANTUS IS EXPECTED TO BE THE LEADING INSULIN ANALOG TILL 2020 ...................................................... 34
• FIGURE 16
CHINA AND INDIA TO LEAD THE MARKET DEMAND FOR HUMAN INSULIN PRODUCTS DURING THE FORECAST PERIOD .................................................................................................................................... 35
• FIGURE 17 MARKET EVOLUTION OF HUMAN INSULIN PRODUCTS ................................................................................... 38
• FIGURE 18 HUMAN INSULIN MARKET : DRIVERS , RESTRAINTS , OPPORTUNITIES , & CHALLENGES ................................ 39
• FIGURE 19 GROWTH IN DIABETIC PATIENT POPULATION ACROSS KEY WHO REGIONS ( 2000 – 2030 )............................ 40
• FIGURE 20 PROPORTION OF GERIATRIC POPULATION , BY COUNTRY ( 2012 VS . 2020 )................................................... 41
• FIGURE 21
• FIGURE 22
GLOBAL TREND IN GOVERNMENT HEALTHCARE EXPENDITURE : DEVELOPED VS . DEVELOPING COUNTRIES ( 2010 – 2012 ).................................................................................................................................. 44
PORTER ’ S FIVE FORCES ANALYSIS ( 2014 ): INCREASING NUMBER OF NEW PRODUCT MANUFACTURERS INCREASES MARKET COMPETITION ....................................................... 53
• FIGURE 23 DELIVERY DEVICES POISED TO GROW AT THE HIGHEST RATE DURING 2015-2020 ...................................... 57
• FIGURE 24
U . S . & EUROPE LEAD GLOBALLY , IN TERMS OF THE NUMBER OF ONGOING HUMAN INSULIN-BASED CLINICAL STUDIES ( 2015 )....................................................................................... 58
• FIGURE 25 LONG-ACTING DRUGS TO LEAD THE INSULIN ANALOGS AND BIOSIMILARS MARKET TILL 2020 ................ 63
• FIGURE 26
ASIA-PACIFIC IS POISED TO BE THE FASTEST GROWING MARKET FOR LONG-ACTING INSULIN ANALOGS AND BIOSIMILAR PRODUCTS DURING FORECAST PERIOD ............................................. 65
sales @ marketsandmarkets . com www . marketsandmarkets . com
22